Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Hytacand
Active Ingredient(s): Candesartan cilexetil 8mg
Hydrochlorothiazide 12.5mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Product: Teveten
Active Ingredient(s): Eprosartan mesylate 735.8mg equivalent to 600mg eprosartan
Dosage Form: Film coated tablet
New Zealand Sponsor: Russells Pharmaceuticals Limited
Manufacturer(s): SmithKline Beecham Pharmaceuticals Co, Bario Certenejas, Cidra, Puerto Rico
SmithKline Beecham Pharmaceuticals Limited, Magpie Wood, Manor Royal, Crawley, Sussex, England
Dated this 26th day of July 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).